Effect of Co-enzyme Q10 on cerebral hemodynamics in diabetic patients.
|
|
Author:
|
ZAHRAA ALHASSANI, AHMED MH AL-MUDHAFAR, LAITH ALDABBAGH
|
Abstract:
|
Background: diabetic patients are at greater risk to have cerebrovascular accidents like ischemic stroke, vascular
dementia and silent lacunar infarctions. They are also deficient in co-enzyme Q10. Previous studies showed that coenzyme
Q10 supplement improves macrovascular complications in diabetic patients.we want to find out the effect of
co-enzyme Q10 supplements on cerebral hemodynamics in diabetic patients we randomly choose 48 patients with
type 2 DM from diabetic center, where they are randomly grouped into two groups. First group: they have
supplement with daily dose of 400mg of co-enzyme Q10 orally for 12 weeks and second group: they have placebo
supplement for 12 weeks. All patients have transcranial Doppler before and after treatment. Mean flow velocity of
first group before treatment was 49.71±7.43 cm/second , while after treatment it increased to 52.92±6.97 cm/second
but this was statistically insignificant (p=0.134). Regarding the second group, MFV before treatment was 50.54±7.91
cm/second, and after treatment was 50.58± 7.1 cm/second. The difference between MFV before and after treatment
was negligible and insignificant (p=0.984).Resistive index of first group before treatment was 0.66 ±0.086, while after
treatment it decreased to 0.61±0.076. This change after treatment was significant (p=0.030). Regarding the second
group, RI before treatment was 0.66± 0.074 and it decreased after treatment to 0.64± 0.072. This change in RI of
second group was insignificant (p= 0.628). Therefore, CoQ10 may lower cerebral arterial resistance and improve
arterial compliance in diabetic patients.
|
Keyword:
|
co-enzyme Q10, cerebral hemodynamics, type 2 DM, transcranial Doppler INTRODUCTION Cardiovascular
|
EOI:
|
-
|
DOI:
|
https://doi.org/10.31838/ijpr/2019.11.01.038
|
Download:
|
Request For Article
|
|
|